Serologicals to Acquire LINCO for $75M to Expand Multiplexing Products Portfolio
Serologicals announced this week that it has made an agreement to acquire LINCO, a life sciences company that focuses on supplying research assays and test kits for the Luminex-based multiplexing platform and other immunoassays.
Under terms of the agreement, Serologicals will pay $64.5 million in cash for the LINCO business, which has 109 employees, plus an additional $10.3 million for the land and buildings currently occupied by LINCO in St. Louis, Mo.
Serologicals said it expects the acquisition to be completed next month.
NIST Extends Call for RNA Sequences
The National Institute of Standards and Technology has extended to April 28 the deadline for RNA sequence contributions to be included in its first round of testing.
The sequences, which will be used in a manner mimicking portions of typical mammalian mRNA transcripts, must be released to the public domain.
NIST is building a library of RNA reference materials as part of a program with the External RNA Controls Consortium. The library of controls is expected to lead to commercial products.
Further details on selection of sequences can be found at http://www.clsi.org.